BioSpace News Archive

BioMidwest

Understanding The Power Of Platelet-Rich Plasma (PRP) Therapy

Movement Orthopedics sees promising results using PRP Therapy to drastically reduce pain and the need for surgery

April 3, 2019
·
2 min read
Achieve Life Sciences to Present at HC Wainwright Global Life Sciences Conference on April 8, 2019

Achieve Life Sciences, Inc. announced that Rick Stewart, Chairman and Chief Executive Officer, will present at HC Wainwright Global Life Sciences Conference being held at the Grosvenor House in Mayfair, London on Monday, April 8 at 11:50 a.m. BST.

April 3, 2019
·
1 min read
Policy

European Patent Office Grants 3rd Charpentier/Doudna Patent Covering Uses of CRISPR/Cas9 in Human and Animals Cells

EPO Patent No. 3,401,400 issued to Dr. Emmanuelle Charpentier, University of California and University of Vienna

April 3, 2019
·
1 min read
Musashi Seimitsu, a Honda Motor Corporation Affiliate Company, Launches Industry-First AI-Powered Solutions and Consortium

Global technology leaders, including Ran Poliakine and SixEye Interactive collaborate to advance robotics through Industry 4.0 at AI Expo Tokyo 2019

April 3, 2019
·
5 min read
CSC Pharmaceuticals Announces the Launch of the Innovative Migraine and Pain Treatment Developed by APR Applied Pharma Research

APR Applied Pharma Research’s patented formulation of Diclofenac 50 mg powder oral solution for migraine treatment and other pain areas is now available in Russia, promoted and commercialized with the brand Dialrapid by the leading pharmaceutical company CSC Pharmaceuticals.

April 3, 2019
·
6 min read
Business

Doximity Appoints Teladoc Health CEO Jason Gorevic to Board of Directors

Healthcare Business Leader to Advise Doximity on Growth and Market Strategies

April 3, 2019
·
2 min read
Business

The Doctors Company Appoints Ellen H. Masterson to Board of Governors

The Doctors Company, the nation’s largest physician-owned medical malpractice insurer, announced the appointment of Ellen H. Masterson, MBA, CPA, to the Board of Governors.

April 3, 2019
·
2 min read
Genetown

Dyne Therapeutics Launches with $50 Million Series A to Develop Targeted Therapies for Muscle Diseases

FORCE™ platform of antibody conjugates will deliver nucleic acids and other molecules for the treatment of serious muscle diseases

April 3, 2019
·
6 min read
TTP plc spin-out Cellular Highways Ltd to Commercialise Next-Generation Cell-Sorting Technology

TTP plc invests £1.7m ($2.2m), to fast-track development of first commercial product, Highway 1™, bench-top cell-sorting instrument

April 3, 2019
·
3 min read
Drug Development

DelMar Pharmaceuticals Receives Approval from MD Anderson Cancer Center’s IRB for Protocol Expansion to Include Maintenance Stage MGMT-unmethylated GBM Patients in Ongoing Phase 2 Trial of VAL-083

DelMar Pharmaceuticals, Inc. announced the University of Texas MD Anderson Cancer Center’s Institutional Review Board has approved a trial protocol amendment to expand DelMar’s ongoing Phase 2 clinical trial of VAL-083 in patients with MGMT-unmethylated glioblastoma.

April 3, 2019
·
6 min read